Filing Details

Accession Number:
0001209191-21-004998
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-22 21:05:26
Reporting Period:
2021-01-21
Accepted Time:
2021-01-22 21:05:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1699488 Vikram Karnani C/O Horizon Therapeutics Plc,
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Evp & President, International No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-01-21 4,904 $0.00 116,333 No 4 M Direct
Ordinary Shares Disposition 2021-01-21 2,173 $77.43 114,160 No 4 F Direct
Ordinary Shares Disposition 2021-01-22 2,731 $76.81 111,429 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Performance Restricted Stock Units (PSUs) Disposition 2021-01-21 4,904 $0.00 4,904 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,905 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2020.
  2. Each PSU represents a contingent right to receive one ordinary share of the Issuer.
  3. The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022.